Your browser doesn't support javascript.
loading
Advances in research on HBV inhibitors based on new targets (1): capsid protein inhibitors / 药学学报
Acta Pharmaceutica Sinica ; (12): 554-565, 2020.
Artículo en Chino | WPRIM | ID: wpr-820854
ABSTRACT
Hepatitis B virus (HBV) capsid protein plays an important role in the life cycle, thus becoming an ideal target for drug design. Capsid protein inhibitors can exert a synergistic antiviral effect with nucleoside drugs by inhibiting the replication of HBV. This paper reviews the research progress of capsid protein inhibitors with different structural types from the perspective of medicinal chemistry.

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Idioma: Chino Revista: Acta Pharmaceutica Sinica Año: 2020 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Idioma: Chino Revista: Acta Pharmaceutica Sinica Año: 2020 Tipo del documento: Artículo